DUX4 and neoplasm: About half of the survey respondents favoured labelling BCOR-CCNB3 and CIC-DUX4 fusion-positive tumours as Ewing-like sarcoma, while the other half either were not sure or favoured labelling these as not Ewing sarcoma.